Back to search
Primary Malignant Peripheral Nerve Sheath Tumors
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Malignant Peripheral Nerve Sheath Tumors trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Malignant Peripheral Nerve Sheath Tumors trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a single center Phase 0 "window of opportunity" trial for the treatment of newly diagnosed, PRC2 deficient, primary malignant peripheral nerve sheath tu…
The ANTARES study is a phase II basket trial designed to evaluate the tissue-agnostic efficacy of the monoclonal anti-PD1 antibody, nivolumab, in patients with…
This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipil…
Exploratory study to examine the effect(s) of Imatinib mesylate treatment on life threatening rare diseases with known associations to one or more Imatinib mesy…